Titles: H.R.7251 — 115th Congress (2017-2018)All Information (Except Text)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Hatch-Waxman Integrity Act of 2018

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Federal Food, Drug, and Cosmetic Act and the Securities Exchange Act of 1934 to prevent the inter partes review process for challenging patents from diminishing competition in the pharmaceutical industry and with respect to drug innovation, and for other purposes.